|
Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - AbelZeta Pharma, Inc. |
Stock and Other Ownership Interests - AbelZeta Pharma, Inc. |
|
|
Employment - AbelZeta Pharma, Inc. |
Stock and Other Ownership Interests - AbelZeta Pharma, Inc. |
|
|
Employment - AbelZeta Pharma, Inc. |
Stock and Other Ownership Interests - AbelZeta Pharma, Inc. |
|
|
Employment - AbelZeta Pharma, Inc. |
Stock and Other Ownership Interests - AbelZeta Pharma, Inc. |
|
|
Employment - AstraZeneca; AstraZeneca (I) |
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I) |
Patents, Royalties, Other Intellectual Property - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca (I) |
|
|
|
Stock and Other Ownership Interests - AstraZeneca and GSK |
Consulting or Advisory Role - AdoRx, Neophore, Epidarex (I) |
|
|
Employment - AstraZeneca; AstraZeneca (I) |
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I) |
Patents, Royalties, Other Intellectual Property - San Raffaele Hospital (Inst) |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
Research Funding - AstraZeneca |
|
|
No Relationships to Disclose |